Oral Oresentation 4

3:54 PM - 4:00 PM JST(6:54 AM - 7:00 AM UTC)

[O04-05] The efficacy and safety of guselkumab as maintenance therapy in Chinese patients with Moderately to Severely Active Ulcerative Colitis: Results of the QUASAR Maintenance Study

*Baili Chen¹, Qian Cao², Yufang Wang³, Shigang Ding⁴, Naizhong Hu⁵, Xuan Guo⁶, Shadi Yarandi⁷, Jiajia Lu⁸, Hongyan Zhang⁷, Minhu Chen¹ (1. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China, 2. Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China, 3. West China Hospital, Sichuan University, Chengdu, P.R. China, 4. Peking University Third Hospital, Beijing, P.R. China, 5. The First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China, 6. Johnson & Johnson, Beijing, P.R. China, 7. Janssen Research & Development, LLC, Spring House, PA, USA, 8. Johnson & Johnson, Shanghai, P.R. China)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.